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Background. By analyzing human immunodeficiency virus type 1 (HIV-1) pol sequences from the Swiss HIV
Cohort Study (SHCS), we explored whether the prevalence of non-B subtypes reflects domestic transmission or
migration patterns.
Methods. Swiss non-B sequences and sequences collected abroad were pooled to construct maximum
likelihood trees, which were analyzed for Swiss-specific subepidemics, (subtrees including $80% Swiss sequences,
bootstrap .70%; macroscale analysis) or evidence for domestic transmission (sequence pairs with genetic distance
,1.5%, bootstrap $98%; microscale analysis).
Results. Of 8287 SHCS participants, 1732 (21%) were infected with non-B subtypes, of which A (n 5 328), C
(n5 272), CRF01_AE (n5 258), and CRF02_AG (n5 285) were studied further. Themacroscale analysis revealed that
21% (A), 16% (C), 24% (CRF01_AE), and 28% (CRF02_AG) belonged to Swiss-specific subepidemics. The microscale
analysis identified 26 possible transmission pairs: 3 (12%) including only homosexual Swiss men of white ethnicity;
3 (12%) including homosexual white men from Switzerland and partners from foreign countries; and 10 (38%)
involving heterosexual white Swiss men and females of different nationality and predominantly nonwhite ethnicity.
Conclusions. Of all non-B infections diagnosed in Switzerland, ,25% could be prevented by domestic
interventions. Awareness should be raised among immigrants and Swiss individuals with partners from high
prevalence countries to contain the spread of non-B subtypes.
Over the last decade, the prevalence of human immu-
nodeficiency virus type 1 (HIV-1) non-B subtypes has
increased in Western Europe. For example, in a time
series extending from 1996 to 2005, Yerly et al [1] noted
a steady increase in non-B subtypes among 822 recently
infected individuals in Switzerland. Such increases are
commonly attributed tomigration, as non-B subtypes are
mostly found among people from non-European origin.
While Swiss subtype B epidemics have already been
studied extensively [2], the possible role of domestic
infections with non-B subtypes is not well investigated. A
phylogenetic study from the United Kingdom identified
2 clusters of epidemiologically linked A1 subtype se-
quences involving men who have sex with men of British
nationality [3]. Significant clustering of non-B subtypes
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was also observed for HIV-1 infected individuals who have ac-
quired the disease through heterosexual contacts. In the United
Kingdom, at least 14% (subtype A) and 6% (subtype C) were
found to be included in UK-specific clusters, therefore suggesting
ongoing transmissions within the UK [4]. Local infections with
non-B subtypes in B-dominated regions have also been identified
by phylogenetic linkage of individuals diagnosed with primary
HIV-1 infection [5]. For example, by screening recently infected
patients Yerly et al [6] identified a subtype CRF11 subepidemic
among intravenous drug users in Western Switzerland.
The present analysis aimed to study 3 questions: How
abundant are non-B subtypes in Switzerland, do Swiss-specific
non-B subepdemics exist (macroscale analysis), and finally, can
we find evidence for ongoing non-B transmissions in Switzer-
land (ie, domestic transmission) by identifying possible trans-
mission pairs (microscale analysis)? In order to address these
questions, we applied a molecular phylogeny approach to non-B
sequences collected from participants of the Swiss HIV Cohort
Study (SHCS).
MATERIALS AND METHODS
Sequences and Patients
The SHCS is a nationwide, prospective, clinic-based cohort
study with continuous enrollment and semiannual study visits
[7, 8]. The SHCS has been approved by ethical committees of all
participating institutions, and written informed consent has
been obtained from participants. The SHCS drug resistance
database contains all HIV resistance tests performed by the
4 laboratories engaged in HIV resistance testing in Switzerland,
stored in a central database developed and hosted by SmartGene
(Zug, Switzerland, IDNS version 3.6.3) [9]. Resistance data stem
from routine clinical testing (60% of tests) and tests performed
retrospectively from frozen repository plasma samples (40% of
tests). The retrospective sequencing was systematically per-
formed using for each patient the earliest available plasma
sample. All laboratories are performing population-based
sequencing of the full protease gene and in minimum codons
28–225 of the reverse transcriptase gene using commercial assays
(Viroseq Vs.1 PE Biosystems; Virsoseq Vs. 2, Abbott AG; vir-
coTYPE HIV-1 Assay, Virco Lab) and in-house methods [10].
Subtyping was performed on the contig of the protease and the
reverse transcriptase sequence using the REGA 2 System [11].
If this method returned inconclusive results, the analysis was
repeated with the Star analyzer (http://www.vgb.ucl.ac.uk/starn.
shtml) [12].
The full SHCS drug resistance database contains 13 750
sequences from 9593 patients. To study the epidemiology of
non-B subtypes in Switzerland, we selected all viral sequences
from individuals who were seen at least once in the SHCS be-
tween 1 January 1996 (earliest availability of plasma samples for
retrospective sequencing) and 30 June 2010 (database closure for
this analysis; see Acknowledgments for Genbank accession
numbers). Time trends in distribution of B and non-B viruses
were analyzed for a subset of these patients who received their
HIV diagnosis between 1 January 1996 and 31 December 2009
(to account for time lags in data reporting) through a positive
HIV test.
The phylogenetic analysis presented here focuses on non-B
subtypes A and C as well as CRF AE and AG, because only these
occur in large enough numbers in Switzerland to perform
meaningful analyses (see Results). In order to identify Swiss-
specific subepidemics, we pooled the earliest available sequence
per SHCS participant with all non-Swiss sequences that were
available for the same subtype/CRF from the Los Alamos Se-
quence database (http://www.hiv.lanl.gov/, date of accession:
September 2010). The following numbers of sequences were
available for the different subtypes/CRF: 2018 (subtype A), 2954
(subtype C), 1455 (CRF01_AE), 1643 (CRF02_AG). To avoid
a distortion of our analysis by convergent evolution driven by
antiretroviral therapy, we removed all major amino acid posi-
tions that are associated with antiretroviral drug resistance ac-
cording to the International AIDS Society - USA (IAS-USA)
guidelines [13] (positions 30, 32, 33, 46, 47, 48, 50, 54, 76, 82, 84,
88, and 90 in the PR and 41, 62, 65, 67, 69, 70, 74, 75, 77, 100,
103, 106, 108, 115, 116, 151, 181, 184, 188, 190, 210, 215, 219,
225, and 236 in the RT).
Demographic (transmission groups, geographical origin
within Switzerland, nationality) and administrative data (sam-
pling year for genotypic test, year of patient’s enrollment in the
cohort, year of first positive HIV test) were obtained from the
SHCS database. Transmission groups were categorized into
heterosexual transmission, men having sex with men, and in-
travenous drug users. Other transmission modes (perinatal,
transfusion risks) were not considered. Information on patient
ethnicity is self-reported according to one of the 5 categories:
white, black, Asian, Hispanic, or other. Patients’ nationalities
were categorized as follows for this analysis: Western Europe, sub-
Saharan Africa, and Southeast Asia. Because other regions only
occurred in small numbers, they were subsumed in 1 category.
Phylogenetic Methods
The phylogenetic methods are described in detail elsewhere [2].
For each of the considered subtypes/CRF (subtypes A and C,
CRF01_AE, and CRF02_AG), we inferred maximum-likelihood
trees (1100 bootstrap runs) using the GTR model with
C-distributed rate heterogeneity implemented in RAxML [14].
These trees were then searched for patterns that indicate Swiss-
specific subepidemics, which were defined as subtrees includ-
ing $80% Swiss sequences and separated by bootstrap sup-
port .70% from the main tree (macroscale analysis). In
addition, trees were analyzed for evidence of domestic trans-
mission, which was defined as possible transmission chains with
non-B virus that involved at least 1 individual of white ethnicity
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and Swiss nationality (microscale analysis). Possible trans-
mission chains were identified on the basis of sequence pairs
with a genetic distance of,1.5% and bootstrap support$98%.
Statistical Analyses
Categorical data were analyzed with the v2 test. Time trends
were investigated with the Cochran-Armitage test for trend.
Statistical calculations were done with Stata 11.1 (Stata Corp).
All P values are 2-sided.
RESULTS
Epidemiology and Time Trends on Non-B Subtypes in
Switzerland
Of 10 540 individuals seen at least once in the Swiss HIV Cohort
Study between 1996 and 2010, subtype information was available
for 8287 individuals (78.6%).Of these 8287persons, 6555 (79.1%)
were infectedwith subtype B. Therewere 4 non-B subtypes, which
occurred at a prevalence of 3% or greater: A (n 5 328; 4.0%), C
(n 5 272; 3.3%), CRF01_AE (n 5 258; 3.1%), and CRF02_AG
(n5 285; 3.4%). All remaining subtypes contributed1% or less
to the sequence database; these were D (n 5 55), F (n 5 74),
G (n5 99), H (n5 8), J (n5 4), K (n5 2), CRF03_AB (n5 2),
CRF06_CPX (n 5 26), CRF10_CD (n 5 1), CRF11_CPX
(n 5 38), CRF12_BF (n 5 8), and CRF13_CPX (n 5 8). In
addition, 267 viral samples (3.2%) were classified as unspecified
recombinants of different viral subtypes by the subtyping
algorithms used [11, 12].
Time trends in occurrence of B and non-B subtypes were
studied for 4767 individuals whose HIV diagnoses (positive
HIV tests) fell between 1996 and 2009. Over this time period, the
proportion of non-B subtype viruses increased from 22% (86
non-B subtypes/385 HIV diagnoses in 1996) to 33% (78 non-B
subtypes/237 HIV diagnoses in 2009) in our study population
(Figure 1A; P trend 5 .004). When analyzing the data for each
mode of HIV acquisition separately, there were also appreciable,
although in some cases nonlinear time trends for increases in
non-B infections among the risk groups of heterosexuals
(Figure 1B; total n 5 2196; 1996: 79 non-B subtypes/174 di-
agnosed (45%); 2009: 63/95 (66%); P, .001), intravenous drug
users (total n5 514; 1996: 5/85 (6%); 2009: 4/7 (57%); P, .001,
not shown). In contrast, the proportion of non-B subtypes re-
mained comparably low among 2056 homosexual men (1996:
2/126 (2%); 2009: 11/135 (8%); P trend , .001, not shown).
Macrolevel Phylogenetic Analyses Identify Swiss-Specific
Non-B Subepidemics
In total, we identified 1143 individuals infected with 1 of the 4
subtypes A, C, CRF01_AE, and CRF02_AG. Characteristics of
these patients are displayed in Table 1. Three subtypes (A, C,
CRF02_AG) are endemic in sub-Saharan Africa, which is also
reflected by the high proportions of individuals with black
ethnicity and African origin in these groups (48% in A, 60% in
C, 61% in CRF02_AG). In contrast, individuals of Asian eth-
nicity and origin only contributed 32% to the Southeast-Asia
endemic subtype CRF01_AE. Each of the 4 subtype groups also
consisted of 24% (C) to 57% (CRF01_AE) individuals of
Western European nationality and white ethnicity (other sub-
types: 28% in CRF02_AG, 38% in A).
In order to identify non-B subepidemics specific for Swit-
zerland, the phylogenetic maximum likelihood trees constructed
on data from the 1143 SHCS participants were searched for
subtrees, which were separated from the full tree with a bootstrap
support .70% and contained at least 80% of Swiss sequences
Figure 1. Time trends in distribution of subtypes in the SHCS. A, All modes of HIV transmission (n5 4767). B, Heterosexual contacts only (n5 2196).
Graphs for intravenous drug users (low numbers) and homosexual men (no discernible time trend) are not shown.
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(Figure 2, macroscale analysis). We empirically found that
these criteria were well suited to detect Swiss subepidemics
because of the low frequency of Swiss sequences relative to the
number of added non-B sequences collected outside of Swit-
zerland, which made the risk for falsely detecting Swiss clusters
small. Overall, 108 Swiss-specific subepidemics involving 254
(22%) of 1143 non-B infected SHCS participants were de-
tected. Ninety-two of these subepidemics predominantly con-
sisted of persons with a heterosexual orientation (including 206
of the 254 individuals, of whom 6 with a history of intravenous
drug use), whereas MSM-dominated clusters were observed in
16 instances (48 individuals). Most of these subepidemics
tended to be small, with only 18% of the Swiss specific sub-
trees consisting of.2 individuals (12% [n5 13] and 5% [n5 5]
with cluster size 3 and 4, respectively, 1 cluster [1%] of size 5,
and 1 cluster [1%] of size 14). Although not reaching sta-
tistical significance, there was a trend for MSM-dominated
subepidemics to form larger transmission chains as illustrated
by a somewhat higher fraction of subepidemics reaching
a size .2 (25%) compared with heterosexually dominated
subepidemics (17%) and the greater size of the largest cluster
(14 vs 5 in heterosexual subepidemics).
As illustrated by Table 2, different patterns of clustering were
observed across subtypes. The proportion of non-B infected
SHCS participants included in Swiss-specific subepidemics var-
ied significantly (Test for heterogeneity in proportions of clus-
tering across subtypes P5 .008). The highest degree of clustering
was observed for the CRF02_AG group, where 80 (28%) of 285
individuals were contained within 34 Swiss specific sub-
epidemics, followed by CRF01_AE with 61 of 258 SHCS par-
ticipants (24%, 23 subepidemics). Corresponding proportions
of clustering sequences (number of clusters) for subtype A and
C were 21% (69 of 328 individuals, 31 clusters) and 16% (44 of
272 individuals, 20 clusters), respectively. Of note, we found
no indication for a time trend in these proportions, irre-
spective of viral subtype (all tests for trend P . .14; data
not shown). In particular, there was no indication for a higher
degree of clustering of viral samples collected in later years,
whichdif founddcould be suggestive for emerging self-
sustained non-B epidemics.
Table 1. Characteristics of SHCS Study Participants Infected With the 4 Most Frequently Observed Non-B Subtypes
CRF01_AE CRF02_AG A C P value
N 258 (100) 285 (100) 328 (100) 272 (100)
Female sex 92 (35.7) 168 (58.9) 213 (64.9) 158 (58.1) ,.001
Ethnicity
White 158 (61.2) 93 (32.6) 146 (44.5) 77 (28.3) ,.001
Black 2 (0.8) 186 (65.3) 170 (51.8) 180 (66.2)
Hispanic 2 (0.8) 2 (0.7) 1 (0.3) 8 (2.9)
Asian 96 (37.2) 4 (1.4) 11 (3.4) 7 (2.6)
Nationality
Western Europe 157 (60.9) 88 (30.9) 133 (40.5) 82 (30.1) ,.001
Sub-Saharan Africa 2 (0.8) 174 (61.1) 159 (48.5) 168 (61.8)
South and East Asia 84 (32.6) 3 (1.1) 10 (3.0) 4 (1.5)
Other 15 (5.8) 20 (7.0) 26 (7.9) 18 (6.6)
Study recruitment in German-speaking
Switzerland (vs French-speaking)a
232 (89.9) 156 (54.7) 235 (71.6) 154 (56.6) ,.001
Mode of HIV acquisition
Heterosexual contacts 189 (73.3) 269 (94.4) 302 (92.1) 247 (90.8) ,.001
Intravenous drug use 9 (3.5) 2 (0.7) 12 (3.7) 9 (3.3)
Homosexual contacts 60 (23.3) 14 (4.9) 14 (4.3) 16 (5.9)
Year of HIV diagnosis (median
[interquartile range])
2002
[1998 to 2005]
2003
[2000 to 2005]
1999
[1995 to 2003]
2000
[1997 to 2004]
,.001
Documented seroconversion or HIV
diagnosis during primary HIV infectionb
36 (14.0) 42 (14.7) 33 (10.1) 32 (11.8) .294
Viral sequence obtained while antiretroviral
therapy naive
215 (83.3) 231 (81.1) 206 (62.8) 176 (64.7) ,.001
First measured CD4 count (median
[interquartile range])
319
[94 to 488]
284
[168 to 460]
283
[154 to 490]
283
[152 to 510]
.882
NOTE. All numbers are no. (%) unless otherwise stated. Tests of significance for differences across subtypes were performed with the v2-test for categorical
variables and the Mann–Whitney U test for continuous variables.
a Individuals from Italian-speaking Switzerland (,4%) were assigned to the German-speaking group due to closer geographical proximity.
b Negative and positive HIV test ,1 year apart or clinical diagnosis of acute retroviral syndrome.
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In order to distinguish between possible domestic trans-
mission and immigration, we analyzed clustering patterns ac-
cording to groups defined by ethnicity and nationality. In
particular, we considered sequences contained within Swiss-
specific clusters to have likely resulted out of domestic trans-
mission events (ie, to have occurred within Switzerland), and the
remaining infections as possibly having been introduced from
abroad through migration. Among the African subtypes A, C,
and CRF02_AG, the overall proportion of individuals with black
ethnicity and Sub-Sahara African nationality included in Swiss-
specific sub-epidemics was 16.4% (81/494; subtype A: 31/157
(19.7%), C: 15/164 (9.1%), CRF02_AG: 35/173 (20.2%); test
for heterogeneity of proportions across subtypes P 5 .0184),
whereas viral sequences from white persons from Western
Europe were linked to Swiss subepidemics in 30.2% of cases (81/
268; subtype A: 29/123 (23.6%); C: 19/66 (28.8%); CRF02_AG:
33/79 (41.8%); test for heterogeneity of proportions across
subtypes P 5 .114). For the Southeast Asia-endemic subtype
CRF01_AE the proportion of sequences from Asian individuals
contained within Swiss-specific clusters was 22.9% (19/83), and
the proportion of clustering sequences among white, Western
European individuals was 24.7% (36/146).
Next, we studied sociodemographic factors associated with
inclusion of sequences in Swiss-specific subepidemics using
logistic regression. Due to expected differences in sociodemo-
graphic factors between the 3 African subtypes A, C, and
CRF02_AG and the Southeast Asian subtype CRF01_AE we
chose to analyze these 2 subtype groups separately. Univariable
logistic regression models restricted to the African subtypes
detected associations of male sex (odds ratio 1.8 [95% confi-
dence interval, 1.3–2.4]), white ethnicity (2.3 [1.7–3.3] com-
pared with blacks), Western European nationality (2.1 [1.5–3.0]
compared with Sub-Saharan Africa) and homosexual mode of
HIV acquisition (2.0 [1.0–2.8] compared with heterosexual in-
fection) with a higher probability for inclusion in Swiss-specific
subepidemics. In contrast, the only positively associated factor
for the Asian subtype CRF01_AE was HIV acquisition through
homosexual contacts (4.6 [2.4–8.8]). Due to the strong cross-
correlation of these demographic characteristics, for example
between nationality and ethnicity or sex and mode of HIV ac-
quisition, multivariable analyses were not performed.
Instead, characteristics of Swiss-specific subepidemics were
further analyzed descriptively and on the basis of demographic
subgroups defined according to ethnicity and mode of HIV ac-
quisition. Figure 3A highlights differences in these demographic
subgroups between the African subtypes and the Asian subtype
CRF01_AE. The major differences found were (1) lower pro-
portions of men who have sex with men in subepidemics of
Figure 2. Swiss-specific subepidemics for subtypes A and C and CRFs AE and AG. Only tips belonging to Swiss patients in a Swiss transmission cluster are
depicted. Each edge emerging from the center corresponds to one transmission cluster. Colors indicate the transmission group (green : heterosexual, red :
MSM, blue : IDU, turquoise: unknown transmission group). Dashed lines indicate patients of nonwhite ethnicity. Stars indicate possible transmission pairs
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Table 2. Characterization of Sequences Included in Swiss-Specific Subepidemics
CRF01_AE CRF02_AG A C
Cluster No cluster P value Cluster No cluster P value Cluster No cluster P value Cluster No cluster P value
N 61 (100) 197 (100) 80 (100) 205 (100) 69 (100) 259 (100) 44 (100) 228 (100)
Female sex 16 (26.2) 76 (38.6) .078 41 (51.3) 127 (62) .099 39 (56.5) 174 (67.2) .099 17 (38.6) 141 (61.8) .004
Ethnicity .044 .001 .040 ,.001
White 40 (65.6) 118 (59.9) 39 (48.8) 54 (26.3) 36 (52.2) 110 (42.5) 24 (54.5) 53 (23.2)
Black 0 (0) 2 (1) 38 (47.5) 148 (72.2) 32 (46.4) 138 (53.3) 19 (43.2) 161 (70.6)
Hispanic 2 (3.3) 0 (0) 1 (1.3) 1 (0.5) 1 (1.4) 0 (0) 1 (2.3) 7 (3.1)
Asian 19 (31.1) 77 (39.1) 2 (2.5) 2 (1) 0 (0) 11 (4.2) 0 (0) 7 (3.1)
Nationality .694 .003 .207 ,.001
Western Europe 37 (60.7) 120 (60.9) 36 (45) 52 (25.4) 30 (43.5) 103 (39.8) 22 (50) 60 (26.3)
Sub-Saharan Africa 0 (0) 2 (1) 36 (45) 138 (67.3) 31 (44.9) 128 (49.4) 15 (34.1) 153 (67.1)
South and East Asia 19 (31.1) 65 (33) 2 (2.5) 1 (0.5) 0 (0) 10 (3.9) 0 (0) 4 (1.8)
Other 5 (8.2) 10 (5.1) 6 (7.5) 14 (6.8) 8 (11.6) 18 (6.9) 7 (15.9) 11 (4.8)
Mode of HIV acquisition ,.001 .311 .439 .078
Heterosexual contacts 30 (49.2) 159 (80.7) 74 (92.5) 195 (95.1) 64 (92.8) 238 (91.9) 36 (81.8) 211 (92.5)
Intravenous drug use 3 (4.9) 6 (3) 0 (0) 2 (1) 1 (1.4) 11 (4.2) 3 (6.8) 6 (2.6)
Homosexual contacts 28 (45.9) 32 (16.2) 6 (7.5) 8 (3.9) 4 (5.8) 10 (3.9) 5 (11.4) 11 (4.8)
Study recruitment in
German-speaking
Switzerland
(vs French-speaking) a
56 (91.8) 176 (89.3) .577 42 (52.5) 114 (55.6) .636 50 (72.5) 185 (71.4) .865 22 (50) 132 (57.9) .333
Documented seroconversion or
HIV diagnosis during
primary HIV infection b
14 (23) 22 (11.2) .020 19 (23.8) 23 (11.2) .007 8 (11.6) 25 (9.7) .634 13 (29.5) 19 (8.3) ,.001
Viral sequence obtained
while antiretroviral
therapy naive
52 (85.2) 163 (82.7) .646 69 (86.3) 162 (79) .162 43 (62.3) 163 (62.9) .925 32 (72.7) 144 (63.2) .224
Year of HIV diagnosis 2003
[2001–2006]
2001
[1997–2005]
.010 2003.5
[1999.5–2006]
2003
[2000–2005]
.563 2000
[1996–2003]
1999
[1995–2003]
.591 2002
[1997–2004.5]
2000
[1997–2003.5]
.164
NOTE. All numbers are no. (%) unless otherwise stated. Tests of significance were performed with the v2-test for categorical variables and the Mann–Whitney U test for continuous variables.
a Individuals from Italian-speaking Switzerland (,4%) were assigned to the German-speaking group due to closer geographical proximity.
b negative and positive HIV test ,1 year apart or clincal diagnosis of acute retroviral syndrome.
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African subtype when compared with subtype CRF01_AE and
(2) the comparably small numbers of white females (n5 4) and
heterosexual asian males (n 5 1) observed in CRF01_AE sub-
epidemics (both present at ,5% and therefore not plotted).
Conversely, the proportion of white and black men and women
appeared to be in balance in clusters of African subtypes.
When performing sensitivity analyses, we found that our
conclusions were robust to methodological variations of our
approach. For instance, the number of Swiss subepidemics de-
creases by ,28% on average if the analysis was restricted to
subtrees with bootstrap support above 95% (instead of .70%).
Likewise, the number of subepidemics changed by ,10% if the
fraction of Swiss sequences defining a Swiss subepidemic was
increased from 80% to 100%.
Identification of Possible Transmission Pairs in Micro-scale
Analysis
In addition to the macro-scale analysis, which identified Swiss-
specific non-B subepidemics, we further aimed to detect possible
transmission pairs by more conservative criteria (micro-scale
analysis), defined as sequence pairs clustering with a bootstrap
support $98% and a genetic distance ,0.015 on the trees cal-
culated for the macro-scale analysis [15, 16].
A total of 26 possible transmission pairs were detected (Figure
3B). Among the 17 pairs infected with African subtypes, themost
frequently observed types of transmission events were among
pairs of heterosexual men and women both of black ethnicity
(n total 5 6; A: n 5 0; CRF02_AG: n 5 2; C: n 5 4), and
heterosexual transmission between individuals of mixed eth-
nicities (n total 5 6; A: n 5 1; C: n 5 1, CRF02_AG: n 5 4).
Noteworthy, in all of the latter 6 transmission pairs, the male
partner was of white ethnicity. Possible heterosexual trans-
mission between white individuals was observed 2 times
(A: n 5 1; CRF02_AG: n 5 1) and possible homosexual trans-
mission between individuals of mixed ethnicity was seen in
3 instances (A: n5 1, C: n5 1, CRF02_AG: n5 1). Among the
patients infected with the Asian subtype CRF01_AE, 5 possible
transmission events between Asian females and white males
were identified, as well as 3 events among white homosexual
men. In addition, 1 possible heterosexual transmission event
included 2 individuals of white ethnicity.
Overall, when also taking information on nationality into
account, local transmission was likely in 16 (62%) of the 26
possible transmission events, because at least 1 partner was of
white ethnicity and Swiss nationality. Of 6 possible events in-
volving homosexual transmission, there were 3 pairs of white
men from Switzerland and 3 pairs, which included white men
from Switzerland and partners from other world regions. Ten
possible transmission pairs consisted of heterosexual white Swiss
men and females from other world regions; 8 of those were of
nonwhite ethnicity. In addition, there were 4 potential hetero-
sexual transmission pairs involving at least 1 white individual
from Western European countries other than Switzerland, thus
making infection in Switzerland seem less certain.
DISCUSSION
By analyzing .8000 HIV-1 pol sequences from Switzerland, we
detected significant increases in the proportion of non-B sub-
types over a time period of 12 years, which were most apparent
among individuals who acquired HIV through heterosexual
contacts. Among the most frequent non-B subtypes with
a prevalence .3% were A, C, CRF01_AE, and CRF02AG. A
macro-scale phylogenetic analysis revealed that only 20% of
newly detected non-B infections among individuals of Asian
or African nationality may have originated from domestic
Figure 3. Distribution of demographic groups (defined on sex, ethnicity, and mode of HIV acquisition) among Swiss-specific subepidemics (A, macro-
scale analysis) and within possible transmission pairs (B, micro-scale analysis). Note that in panel A only demographic groups with a proportion$5% are
plotted. Mode of HIV acquisition is heterosexual if not mentioned otherwise. f, female; m, male; msm; men who have sex with men.
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transmission, whereas the remainder of infections most likely
have occurred outside of Switzerland. Although this proportion
was higher among white, Western European individuals and
reaching up to 42% for subtype CRF02_AG, substantial num-
bers of sequences were not associated with Swiss-specific sub-
epidemics, possibly reflecting infections acquired during travel
and stays abroad [17]. Along these lines, themacro-scale analysis
further indicated that, consistent with findings from a previous
analysis of the Swiss subtype B epidemic among heterosexuals
[2], the non-B epidemic can only be maintained through
frequent reintroduction from abroad. The presence of self-
sustained non-B epidemics would lead to large transmission
chains in the phylogenetic tree (similar to those observed among
subtype B infectedMSM in Switzerland [2]), and possibly also to
an increase in the ratio of clustering (ie, Swiss-specific) and
nonclustering sequences over time. Neither was seen in our
macro-scale analysis.
Our observations from the macro-scale analysis are in line
with results from a modeling study, which also found a much
greater contribution of migration to newly diagnosed non-B
infections among Africans than domestic transmission [18]. The
Dutch study predicted a proportion of 60% of newly diagnosed
infections among African immigrants to have occurred outside
the Netherlands, whereas in our study 80% and more of all
non-B infections among Africans may have originated outside of
Switzerland, given that only 20% of all sequences from this
group were contained within Swiss-specific clusters.
Nevertheless, our micro-scale analysis yielded substantial ev-
idence for possible domestic non-B transmissions, because, even
with a very conservative criterion, we detected 16 instances of
genetically linked viral samples including at least 1 individual of
white ethnicity and Swiss nationality. A surprisingly large pro-
portion (10/16, 63%) of these possible local transmission events
involved a constellation of white Western European males and
nonwhite females, which is suggestive for an important role of
interracial partnerships in transmission of non-B subtypes
within Switzerland. These patterns are also consistent with
a contribution of sex tourism or prostitution to non-B infections
in Switzerland, as occasionally reported by newly HIV-diagnosed
individuals as a possible source of infection [Gu¨nthard, un-
published observation].
Several study limitations should be noted. Our analysis is
subject to the usual and unavoidable caveats associated with
molecular epidemiological analyses such as sampling bias (see
Kouyos et al [2] for a detailed discussion), but these problems
are substantially alleviated by the high representativeness of the
SHCS [8]. Furthermore, the criteria used to identify possible
transmission pairs in the micro-scale analysis were strict and
have successfully been used previously, confirmed by clonal
sequences of a second gene, to establish linkages between
HIV-infected individuals with primary HIV infection [16].
However, linkage between individuals can never be established
with absolute certainty due to possible intermediary links, which
may not have been sampled. Moreover, we cannot fully exclude
that white and nonwhite individuals may have been infected
abroad and later migrated to Switzerland together. However, the
finding that 4 of the 26 possible transmission pairs were em-
bedded in Swiss-specific subepidemics of size 3 (n 5 3) or
greater (size 14: n 5 1; Figure 2) provides strong evidence that
domestic infections with the 4 most prevalent non-B subtypes
indeed do occur in Switzerland.
Overall, our results stand in contrast to findings of the sub-
type B epidemics among intravenous drug users (IDUs) and
men who have sex with men (MSMs) in Switzerland, which were
driven by domestic transmission [2], but also to the common
notion that HIV infections with non-B subtypes are mainly
a problem of migration. Instead, the epidemiology of non-B
HIV-1 in Europe should be understood as the combined result
of both migration and domestic transmission. Moreover, these
findings have significant public health implications, because
they demonstrate that less than one-fourth of all non-B in-
fections diagnosed in Switzerland could possibly be prevented by
local interventions, and they also suggest that awareness should
be raised among immigrants and Swiss individuals with partners
from countries with high HIV prevalence to contain the spread
of HIV in Switzerland.
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